Women Slowly Coming To Terms with Female Libido Drug Addyi

Flibanserin better known as Addyi has been launched into the market and seeks to address the issue of sexual dysfunction and low libido especially in women who have entered menopause. For more than a decade, women felt that they were sidelined when it came to overcoming low sex drive which is common in pre-menopausal women. They were up in arms wondering why men had several options for boosting their libido.

order addyi onlineMen can count on Viagra which has been in the market for more than 17 years and has evolved into other forms. They also have tadalafil better known as Cialis which is quite popular. The wait for a drug that will help women deal with low sexual desire is finally over as Addyi or the “woman Viagra” hits the shelves.

According to Kim Wallen, professor of psychology at Emory University, the launching of Addyi marks a new chapter in sexual dysfunction in women. In fact, she believes that the new drug will pave way for other drugs just as Viagra did for men. The pink pill was rejected twice by the Food and Drug Administration (FDA) for not showing positive effects was finally given the green light by the regulatory body.

addyi women viagraThough it serves the same purpose as Viagra, Cialis, and other male drugs, Addyi works in a completely different way. Unlike male libido drugs which stimulate the production of Nitric oxide (NO) that encourages vasodilation and push more blood into the penile region, Addyi targets serotonin which triggers brain impulses and make a woman desire sex.

Latest statistics indicate that though women were eagerly waiting for their own Viagra, the uptake can’t be compared to that of male Viagra after its launch into the market. Critics blame the slow acceptance on several reasons that still cast doubts on the drug. The most notable is the earlier rejection by the FDA and the reluctant approval later on.

Another reason is because the drug follows the same approach to that used in developing the little blue pill for men. Adriane Fugh-Berman, doctor at Georgetown University argues that sexual desire in women is quite different from men. In men, it is more physical while in women it is more psychological. Researchers should therefore aim at mind therapy.

Doctor Lisa Dabney of Mount Sinai Hospital, New York, states that many patients choose not to use the pink pill once they are told to avoid alcohol. The stringent conditions set by FDA such as requiring a doctor to be trained and licensed to offer the drug is also affecting the rate of acceptance of Addyi, the female libido drug.

Back to Top